1. Home
  2. MCY vs CRSP Comparison

MCY vs CRSP Comparison

Compare MCY & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCY
  • CRSP
  • Stock Information
  • Founded
  • MCY 1961
  • CRSP 2013
  • Country
  • MCY United States
  • CRSP Switzerland
  • Employees
  • MCY N/A
  • CRSP N/A
  • Industry
  • MCY Property-Casualty Insurers
  • CRSP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MCY Finance
  • CRSP Health Care
  • Exchange
  • MCY Nasdaq
  • CRSP Nasdaq
  • Market Cap
  • MCY 3.7B
  • CRSP 3.4B
  • IPO Year
  • MCY N/A
  • CRSP 2016
  • Fundamental
  • Price
  • MCY $52.25
  • CRSP $47.87
  • Analyst Decision
  • MCY Strong Buy
  • CRSP Buy
  • Analyst Count
  • MCY 1
  • CRSP 21
  • Target Price
  • MCY $80.00
  • CRSP $75.42
  • AVG Volume (30 Days)
  • MCY 951.7K
  • CRSP 2.7M
  • Earning Date
  • MCY 02-11-2025
  • CRSP 02-11-2025
  • Dividend Yield
  • MCY 2.43%
  • CRSP N/A
  • EPS Growth
  • MCY 385.68
  • CRSP N/A
  • EPS
  • MCY 8.45
  • CRSP N/A
  • Revenue
  • MCY $5,475,633,000.00
  • CRSP $37,314,000.00
  • Revenue This Year
  • MCY N/A
  • CRSP $227.76
  • Revenue Next Year
  • MCY $7.13
  • CRSP $353.05
  • P/E Ratio
  • MCY $6.19
  • CRSP N/A
  • Revenue Growth
  • MCY 18.27
  • CRSP N/A
  • 52 Week Low
  • MCY $44.19
  • CRSP $36.52
  • 52 Week High
  • MCY $80.72
  • CRSP $90.62
  • Technical
  • Relative Strength Index (RSI)
  • MCY 46.18
  • CRSP 58.27
  • Support Level
  • MCY $50.27
  • CRSP $38.28
  • Resistance Level
  • MCY $62.84
  • CRSP $55.88
  • Average True Range (ATR)
  • MCY 2.69
  • CRSP 2.87
  • MACD
  • MCY 0.74
  • CRSP 1.07
  • Stochastic Oscillator
  • MCY 28.01
  • CRSP 54.50

About MCY Mercury General Corporation

Mercury General Corp is an insurance holding company. It is engaged in writing personal automobile insurance and provides related property and casualty insurance products. The Company offers the following types of automobile coverage: collision, property damage, bodily injury ("BI"), comprehensive, personal injury protection ("PIP"), underinsured and uninsured motorist, and other hazards. The Company offers the following types of homeowners coverage: dwelling, liability, personal property, and other coverages.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: